How is COVID-19 treated?

Mild cases of COVID-19 may not require treatment. However, if you have a severe case, Monoclonal antibodies (mAB) can be administered to a patient via intravenous (IV) infusion in order to treat COVID-19. Monoclonal antibody treatment can only be provided under the order of a physician or licensed practitioner.

This treatment is authorized for patients meeting the criteria specified in the FDA’s Emergency Use Authorizations (EUAs) for these treatments, and, due to the extremely limited supply, patients must:

• Have tested positive for COVID-19 within the prior 7 days
• Be symptomatic
• Be at an increased risk of severe disease
• Not yet be sick enough to be hospitalized
• Learn more about mAB at https://coronavirus.delaware.gov/monoclonal-antibody-infusions/